| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kiniksa Pharmaceuticals International, Plc (KNSA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. KNSA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 626.2K | $34.51M | - | |
| Other | 143.9K | $7.93M | - | |
| Dir | 36.5K | $2.01M | - | |
| COO | 28.7K | $1.58M | - | |
| CFO | 22.8K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE | 12,409 | $21.06 | $261,333.54 | -13.9% | +45.4% | +125.4% | |
| Feb 10, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE | 14,000 | $19.57 | $273,980.00 | -14.6% | +36.9% | +128.1% | |
| Jan 13, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE | 14,000 | $18.24 | $255,413.15 | -7.2% | +13.9% | +112.4% | |
| Dec 16, 2024 | Tessari Eben | Chief Operating Officer | Sale+OE | 23,017 | $20.44 | $470,467.48 | -19.3% | +13.0% | +103.6% | |
| Dec 9, 2024 | Ragosa Mark | Chief Financial Officer | Sale+OE | 27,829 | $21.34 | $593,997.43 | -37.7% | -2.2% | +93.0% | |
| Dec 5, 2024 | Ragosa Mark | Chief Financial Officer | Sale+OE | 15,116 | $21.37 | $323,008.80 | -18.0% | +2.0% | +98.6% | |
| Nov 29, 2024 | Megna Michael R | Chief Accounting Officer | Sale+OE | 8,646 | $22.45 | $194,102.70 | -14.0% | -11.1% | +92.6% | |
| Nov 18, 2024 | Tessari Eben | Chief Operating Officer | Sale+OE | 17,000 | $21.04 | $357,680.00 | -14.2% | -9.1% | +92.0% | |
| Nov 6, 2024 | Patel Sanj K | Chairman &CEO | Sale+OE | 89,561 | $23.00 | $2,059,903.00 | -53.0% | -18.6% | +67.7% | |
| Oct 15, 2024 | Tessari Eben | Chief Operating Officer | Sale+OE | 17,000 | $26.87 | $456,790.00 | -13.4% | -32.9% | +43.6% |